Evidence map›Paper›PMID 25781188›Full record

ArticlePloS one2015

MRSA clonal complex 22 strains harboring toxic shock syndrome toxin (TSST-1) are endemic in the primary hospital in Gaza, Palestine.

Nahed Al Laham, José R Mediavilla, Liang Chen, Nahed Abdelateef, Farid Abu Elamreen, Christine C Ginocchio, Denis Pierard, Karsten Becker, Barry N Kreiswirth

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Methicillin-ResistantToxins · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Prevalence ofMicroorganisms · 2023
    Article
  7. Article
  8. Pet animals as reservoirs for spreading methicillin-resistantJournal of advanced veterinary and animal research · 2023
    Article
  9. Article
  10. Characterisation of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Genomic analysis of methicillin-resistantFrontiers in microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Characteristics of methicillin-resistantNew microbes and new infections · 2020
    Article
  16. Article
  17. Article
  18. Genetic Variability of Methicillin ResistantOsong public health and research perspectives · 2019
    Article
  19. Molecular Characterization of Methicillin ResistantFrontiers in public health · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nahed Al LahamDepartment of Laboratory Medicine, Al Azhar University-Gaza, Gaza Strip, Palestine; Public Health Research Institute, Rutgers University, Newark, New Jersey, United States of America.
José R MediavillaPublic Health Research Institute, Rutgers University, Newark, New Jersey, United States of America.
Liang ChenPublic Health Research Institute, Rutgers University, Newark, New Jersey, United States of America.
Nahed AbdelateefThe Central Laboratories, Ministry of Health, Gaza Strip, Palestine.
Farid Abu ElamreenThe Central Laboratories, Ministry of Health, Gaza Strip, Palestine.
Christine C GinocchioDepartment of Pathology and Laboratory Medicine, North Shore-LIJ Health System, Lake Success, New York, United States of America; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York, United States of America.
Denis PierardInstitute of Medical Microbiology, University Hospital of Brussels, Brussels, Belgium.
Karsten BeckerInstitute of Medical Microbiology, University Hospital of Muenster, Muenster, Germany.
Barry N KreiswirthPublic Health Research Institute, Rutgers University, Newark, New Jersey, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in both community and healthcare-related settings worldwide. Current knowledge regarding the epidemiology of S. aureus and MRSA in Gaza is based on a single community-based carriage study. Here we describe a cross-sectional analysis of 215 clinical isolates collected from Al-Shifa Hospital in Gaza during 2008 and 2012.

methodsAll isolates were characterized by spa typing, SCCmec typing, and detection of genes encoding Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin (TSST-1). Representative genotypes were also subjected to multilocus sequence typing (MLST). Antibiotic susceptibility testing was performed using VITEK2 and MicroScan.

resultsMRSA represented 56.3% of all S. aureus strains, and increased in frequency from 2008 (54.8%) to 2012 (58.4%). Aside from beta-lactams, resistance was observed to tetracycline, erythromycin, clindamycin, gentamicin, and fluoroquinolones. Molecular typing identified 35 spa types representing 17 MLST clonal complexes (CC), with spa 998 (Ridom t223, CC22) and spa 70 (Ridom t044, CC80) being the most prevalent. SCCmec types I, III, IV, V and VI were identified among MRSA isolates, while type II was not detected. PVL genes (lukF/S-PV) were detected in 40.0% of all isolates, while the TSST-1 gene (tst) was detected in 27.4% of all isolates, with surprisingly high frequency within CC22 (70.4%). Both PVL and TSST-1 genes were found in several isolates from 2012.

conclusionsMolecular typing of clinical isolates from Gaza hospitals revealed unusually high prevalence of TSST-1 genes among CC22 MRSA, which is noteworthy given a recent community study describing widespread carriage of a CC22 MRSA clone known as the 'Gaza strain'. While the latter did not address TSST-1, tst-positive spa 998 (Ridom t223) has been detected in several neighboring countries, and described as endemic in an Italian NICU, suggesting international spread of a 'Middle Eastern variant' of pandemic CC22 strain EMRSA-15.

Indexed as

Bacterial ToxinsEnterotoxinsExotoxinsHospitalsLeukocidinsMethicillin-Resistant Staphylococcus aureusMiddle EastSuperantigensBacterial Toxinsenterotoxin F, StaphylococcalEnterotoxinsExotoxinsLeukocidinsPanton-Valentine leukocidinSuperantigens

Identifiers

PMID25781188
PMCPMC4364023

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.